Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Payment Type: L/C,T/T
Incoterm: FOB,CFR,CIF,EXW
CS-274 was approved by the United States and the European Union in 2003 to be used in combination with other anti-emetic drugs to prevent acute or delayed nausea during the initial or repeated treatment of high or moderate vomiting tumors and vomiting.
Product Categories : API Intermediates > Intermediate for CAS 170729-80-3
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.